...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

Hmmm , someone wants shares, haven't seen this volume in long long time... There is nothing more i would love to see is this little buying here as  a prelude to something really big, like someone knows something is happening ,  but with DM at the helm nothing really  big large like a major partnership deal  or buyout with BP  has yet to  get done , 2013  and I am not that positive its in the works yet. would love to be wrong once here 

Share
New Message
Please login to post a reply